Medical Health & Life Science Research News

North America active implantable medical devices market predicted to grow USD 9.27 billion by 2021 according to new research report

North America active implantable medical devices market predicted to grow USD 9.27 billion by 2021 according to new research report

Regional and country-level analysis and forecasts of the North America Active Implantable Medical Devices Market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped

- Advertising -

According to the report “North America Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 To 2021)” published by Market Data Forecast, the North America Active Implantable Medical Devices Market is estimated to grow at a 7.53% CAGR from 2016 to 2021 and it is projected that the North-America market was valued at USD 6.45 billion in 2016 and is anticipated to reach USD 9.27 billion by 2021.

Browse details of 145 pages research report on North America Active Implantable Medical Devices Market at www.marketdataforecast.com/market-…ices-market-5029/  

Medical Device (AIMD) Directive 90385EEC defines an active implantable medical device as any active implantable medical device refers to any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure.

North America Active Implantable Medical Devices Market Overview:

The demand for active implantable medical devices is increasing due to increasing occurrences of cardiovascular diseases and increasing incidences of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world.

- Advertising -

Implantable cardioverter defibrillators and implantable cardiac pacemakers are the key medical devices used for the treatment of different cardiovascular conditions. High occurrence of cardiovascular diseases depicts increased demand for these devices.

Neurological disorders are characterized by dysfunction in the nervous system. These conditions include Parkinson’s disease, Alzheimer’s disease, fecal incontinence, epilepsy and depression.

According to Alzheimer’s Association, approximately 5.3 million people aged 65 years and older were reported to have Alzheimer’s disease in 2015 in the U.S. It further reported that these numbers are expected to reach 7.1 million in 2025 and about 13.8 million in 2050.

Report: www.marketdataforecast.com/market-…29/request-sample

North America Active Implantable Medical Devices Market Segmentation:

The North-America market for Active Implantable Medical Devices market is segmented into Product and Region. On the basis of Product, it is segmented into Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator and Implantable Hearing Devices.

Cardioverter defibrillators held the largest share in the active implantable medical devices market. Transvenous implantable cardioverter defibrillator is further segmented into biventricular implantable cardioverter defibrillators, dual-chamber implantable cardioverter defibrillators.

Single-chamber implantable cardioverter defibrillators accounted for the largest share in this market segment followed by subcutaneous implantable cardioverter defibrillators. The neurostimulators market is projected to witness the highest growth rate in this market segment.

On the basis of geography,

The market is analyzed under various regions namely U.S. and Canada. North America held the largest share in the regional segment of the market.

The large share of this regional segment can be credited to the growth in geriatric population, surge in the occurrence of cardiovascular and neurological diseases, high accessibility to advanced technologies, rise in the development of innovative and technologically advanced products, and rise in the healthcare expenditure in the region.

Some of the major companies dominating the market:

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • LivaNova PLC.
  • Cochlear Limited
  • MED-EL
  • Sonova Holding AG
  • William Demant Holding A/S
  • Nurotron Biotechnology Co. Ltd

Report: www.marketdataforecast.com/market-…rket-5029/inquire

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...